Evaluation of different doses of midazolam for amnesia and sedation in general anesthesia

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT201101293468N5

Enrollment

Registered

2011-04-04

Start date

2010-04-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

amnesia. Dissociative amnesia

Interventions

Intervention 1: in group 1 patiens were received intravenous midazolam 1 milligram just before entering to the operating room. Intervention 2: in group 2, patients were given 3 milligram intravenously

Prevention

in group 1 patiens were received intravenous midazolam 1 milligram just before entering to the operating room.

in group 2, patients were given 3 milligram intravenously just before entering to the operating room.

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: 1- ASA Class=1,2; 2- Elective outpatient surgical procedure under general anesthesia; 3- age below 60 years; 4- weight between 50-100 kilogram; 5- No visual disturbance; 6- No auditory disturbance; 7- No memory disturbance; 8- No tranqulizer drug consumption. Exclusion criteria: known allergy to study drug.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Amnesia. Timepoint: after 4 hours. Method of measurement: events and poster recall.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Reza Hajiesmaeili

Shahid Sadoughi University of Medical Sciences and Health Services

hajiesmaeili@ssu.ac.ir+98 35 1626 9979

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026